EC regimen
|
WikiDoc Resources for EC regimen |
|
Articles |
|---|
|
Most recent articles on EC regimen |
|
Media |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on EC regimen at Clinical Trials.gov Clinical Trials on EC regimen at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on EC regimen
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Patient resources on EC regimen Discussion groups on EC regimen Patient Handouts on EC regimen Directions to Hospitals Treating EC regimen Risk calculators and risk factors for EC regimen
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for EC regimen |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aparna Vuppala, M.B.B.S. [2]
Synonyms and keywords:EC Regimen; Etoposide-Carboplatin Regimen
Overview
EC regimen refers to a regimen consisting of etoposide and carboplatin used for the treatment of Extensive-stage small cell lung cancer.
Regimen
EEtoposide
CCarboplatin